Table of Contents:
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Type
2.3.2 Market Size By Technology
2.3.3 Market Size By Application
2.3.4 Market Size By End User
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material & Biochemical Reagent Suppliers
3.4.2 Immunoassay Kit & Diagnostic Test Manufacturers
3.4.3 Instrumentation & Analytical System Providers
3.4.4 Distribution Channels & End-Use Healthcare Facilities
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Pricing Analysis & Forecast
4.1.1 Overview
4.1.2 Pricing Analysis & Forecast By Type, 2022–2035
4.1.3 Immunoprotein Assay Kit Pricing Benchmarking by Key Players
4.1.4 Automated Immunoassay Platform vs Manual Test Cost Analysis
4.2 Technology Adoption Trends
4.2.1 Overview
4.2.2 Chemiluminescence Immunoassay (CLIA) Expansion Trends
4.2.3 ELISA-to-Automated Immunoassay Transition
4.2.4 Immunoturbidimetry & High-Throughput Testing Adoption
4.2.5 Electrophoresis-Based Protein Analysis Utilization
4.3 Application Demand Analysis
4.3.1 Overview
4.3.2 Infectious Disease Testing Demand Trends
4.3.3 Autoimmune Disease Diagnostics Expansion
4.3.4 Oncology Biomarker Testing Growth
4.3.5 Cardiovascular Risk Assessment (hs-CRP) Adoption
4.3.6 Allergy & Endocrine Testing Applications
4.4 End-User Market Analysis
4.4.1 Overview
4.4.2 Hospitals & Clinical Laboratories Adoption Trends
4.4.3 Diagnostic Centers Testing Volume Growth
4.4.4 Academic & Research Institute Applications
4.4.5 Pharmaceutical & Biotechnology Company Utilization
4.5 Workflow & Automation Trends
4.5.1 Overview
4.5.2 Fully Automated Immunoassay Analyzer Adoption
4.5.3 High-Throughput Laboratory Integration Trends
4.5.4 AI-Based Diagnostic Interpretation Systems
4.5.5 Digital Laboratory Information System (LIS) Integration
5. Immunoprotein Diagnostic Testing Market Segmental Analysis & Forecast, By Type, 2022–2035, Value (USD Billion)
5.1 Introduction
5.2 Immunoglobulin Diagnostic Tests
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022–2035
5.3 C-Reactive Protein Diagnostic Tests
5.4 Free Light Chain Diagnostic Tests
5.5 Complement System Protein Tests
5.6 Pre-Albumin Tests
5.7 Haptoglobin Tests
5.8 Others
6. Immunoprotein Diagnostic Testing Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)
6.1 Introduction
6.2 ELISA
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022–2035
6.3 Chemiluminescence Immunoassay/CLIA
6.4 Radioimmunoassay/RIA
6.5 Immunoturbidity Assay
6.6 Immunoprotein Electrophoresis
6.7 Others
7. Immunoprotein Diagnostic Testing Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)
7.1 Introduction
7.2 Infectious Disease Testing
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022–2035
7.3 Autoimmune Disease Testing
7.4 Oncology Testing
7.5 Allergy Testing
7.6 Endocrine Testing
7.7 Cardiovascular Testing
7.8 Others
8. Immunoprotein Diagnostic Testing Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals & Clinical Laboratories
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022–2035
8.3 Diagnostic Centres
8.4 Academic & Research Institutes
8.5 Pharmaceutical & Biotechnology Companies
9. Immunoprotein Diagnostic Testing Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)
9.1 Introduction
9.2 North America
9.2.1 Key Trends
9.2.2 Immunoprotein Diagnostic Testing Market Size & Forecast, By Type, 2022–2035
9.2.3 Immunoprotein Diagnostic Testing Market Size & Forecast, By Technology, 2022–2035
9.2.4 Immunoprotein Diagnostic Testing Market Size & Forecast, By Application, 2022–2035
9.2.5 Immunoprotein Diagnostic Testing Market Size & Forecast, By End User, 2022–2035
9.2.6 Immunoprotein Diagnostic Testing Market Size & Forecast, By Country, 2022–2035
9.2.6.1 USA
9.2.6.2 Canada
9.3 Europe
9.3.1 Key Trends
9.3.2 Immunoprotein Diagnostic Testing Market Size & Forecast, By Type, 2022–2035
9.3.3 Immunoprotein Diagnostic Testing Market Size & Forecast, By Technology, 2022–2035
9.3.4 Immunoprotein Diagnostic Testing Market Size & Forecast, By Application, 2022–2035
9.3.5 Immunoprotein Diagnostic Testing Market Size & Forecast, By End User, 2022–2035
9.3.6 Immunoprotein Diagnostic Testing Market Size & Forecast, By Country, 2022–2035
9.3.6.1 Germany
9.3.6.2 UK
9.3.6.3 France
9.3.6.4 Italy
9.3.6.5 Spain
9.3.6.6 Russia
9.3.6.7 Poland
9.3.6.8 Rest of Europe
9.4 Asia-Pacific
9.4.1 Key Trends
9.4.2 Immunoprotein Diagnostic Testing Market Size & Forecast, By Type, 2022–2035
9.4.3 Immunoprotein Diagnostic Testing Market Size & Forecast, By Technology, 2022–2035
9.4.4 Immunoprotein Diagnostic Testing Market Size & Forecast, By Application, 2022–2035
9.4.5 Immunoprotein Diagnostic Testing Market Size & Forecast, By End User, 2022–2035
9.4.6 Immunoprotein Diagnostic Testing Market Size & Forecast, By Country, 2022–2035
9.4.6.1 China
9.4.6.2 India
9.4.6.3 Japan
9.4.6.4 South Korea
9.4.6.5 Australia
9.4.6.6 ASEAN Countries
9.4.6.7 Rest of Asia-Pacific
9.5 Latin America
9.5.1 Key Trends
9.5.2 Immunoprotein Diagnostic Testing Market Size & Forecast, By Type, 2022–2035
9.5.3 Immunoprotein Diagnostic Testing Market Size & Forecast, By Technology, 2022–2035
9.5.4 Immunoprotein Diagnostic Testing Market Size & Forecast, By Application, 2022–2035
9.5.5 Immunoprotein Diagnostic Testing Market Size & Forecast, By End User, 2022–2035
9.5.6 Immunoprotein Diagnostic Testing Market Size & Forecast, By Country, 2022–2035
9.5.6.1 Brazil
9.5.6.2 Argentina
9.5.6.3 Mexico
9.5.6.4 Colombia
9.5.6.5 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Key Trends
9.6.2 Immunoprotein Diagnostic Testing Market Size & Forecast, By Type, 2022–2035
9.6.3 Immunoprotein Diagnostic Testing Market Size & Forecast, By Technology, 2022–2035
9.6.4 Immunoprotein Diagnostic Testing Market Size & Forecast, By Application, 2022–2035
9.6.5 Immunoprotein Diagnostic Testing Market Size & Forecast, By End User, 2022–2035
9.6.6 Immunoprotein Diagnostic Testing Market Size & Forecast, By Country, 2022–2035
9.6.6.1 UAE
9.6.6.2 Saudi Arabia
9.6.6.3 Qatar
9.6.6.4 South Africa
9.6.6.5 Rest of Middle East & Africa
10. Competitive Landscape
10.1 Key Players' Positioning
10.2 Competitive Developments
10.2.1 Key Strategies Adopted (%), By Key Players, 2025
10.2.2 Year-Wise Strategies & Development, 2022–2025
10.2.3 Number Of Strategies Adopted By Key Players, 2025
10.3 Market Share Analysis, 2025
10.4 Type/Service & Technology Benchmarking
10.4.1 Type/Service Specifications & Features By Key Players
10.4.2 Type/Service Heatmap By Key Players
10.4.3 Technology Heatmap By Key Players
10.5 Industry Start-Up & Innovation Landscape
10.6 Key Company Profiles
10.6.1 Beckman Coulter Inc. (Danaher)
10.6.1.1 Company Overview & Snapshot
10.6.1.2 Type/Service Portfolio
10.6.1.3 Key Company Financials
10.6.1.4 SWOT Analysis
10.6.2 Abbott Diagnostics
10.6.3 Siemens Healthineers AG
10.6.4 F. Hoffmann-La Roche Ltd.
10.6.5 Thermo Fisher Scientific Inc.
10.6.6 bioMérieux SA
10.6.7 Bio-Rad Laboratories Inc.
10.6.8 Qiagen N.V.
10.6.9 Ortho Clinical Diagnostics (QuidelOrtho)
10.6.10 Sysmex Corporation
10.6.11 Luminex Corporation (DiaSorin)
10.6.12 QuidelOrtho
10.6.13 Instrumentation Laboratory (Werfen)
10.6.14 Trinity Biotech plc
10.6.15 Randox Laboratories Ltd.
10.6.16 Binding Site Group (Thermo Fisher)
10.6.17 Sebia SA
10.6.18 Helena Laboratories
10.6.19 R&D Systems (Bio-Techne)
10.6.20 Merck KGaA (MilliporeSigma)
11. Analyst Recommendations
11.1 SNS Insider Opportunity Map
11.2 Industry Low-Hanging Fruit Assessment
11.3 Market Entry & Growth Strategy
11.4 Analyst Viewpoint & Suggestions on Market Growth
12. Assumptions
13. Disclaimer
14. Appendix
14.1 List Of Tables
14.2 List Of Figures
Frequently Asked Questions
The market is expected to grow at a CAGR of 7.54% from 2026 to 2035.
The market was valued at USD 10.28 Billion in 2025.
Rising incidence of chronic diseases, autoimmune disorders, and hematological malignancies requiring consistent immunoprotein biomarker monitoring.
Immunoglobulin Diagnostic Tests dominated the market with 28.15% share in 2025.
North America dominated the market in 2025.